Irreversible fibrosis of the pancreas causing pain, exocrine insufficiency, and diabetes.
Also known as: chronic pancreatitis, CP
Overview
Chronic, progressive, fibroinflammatory disease of the pancreas characterized by irreversible structural damage leading to chronic abdominal pain, exocrine insufficiency (steatorrhea, malabsorption), and endocrine insufficiency (diabetes mellitus).
Epidemiology
Prevalence ~50 per 100,000 in the US. Higher prevalence in alcohol users and smokers. Male predominance. Increased risk of pancreatic cancer (4-fold over baseline).
Try two board-style Chronic Pancreatitis questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1GastrointestinalMedium
A 49-year-old man with chronic alcohol use has epigastric pain radiating to the back and steatorrhea. Which of the following best explains his greasy stools?
AReduced hepatic bile output
BReduced pancreatic insulin output
CIncreased gastric acid output
DImpaired colonic water uptake
EDecreased pancreatic lipase
Reveal answer & full explanation
Correct answer: E — Decreased pancreatic lipase
AReduced hepatic bile output
BReduced pancreatic insulin output
CIncreased gastric acid output
DImpaired colonic water uptake
EDecreased pancreatic lipase✓
Why Decreased pancreatic lipase is correct
Years of alcohol use produce chronic pancreatitis with progressive exocrine gland destruction.
Without pancreatic lipase, dietary fat is not digested or absorbed, so it passes as bulky greasy steatorrhea.
Boring epigastric pain radiating to the back plus the alcohol history localizes the injury to the pancreas.
Why the others are wrong
Reduced hepatic bile output — Cholestasis can impair fat emulsification, but the back-radiating pain and alcohol history point at the pancreas, not the biliary tree; this is a plausible-organ trap.
Increased gastric acid output — Acid hypersecretion drives ulcer pain and dyspepsia, not fat malabsorption, and would not produce oily stools.
Impaired colonic water uptake — Defective water reabsorption yields watery, not fatty, diarrhea and does not explain undigested fat.
Reduced pancreatic insulin output — chronic pancreatitis often destroys islet cells over time and causes pancreatogenic (type 3c) diabetes, so the organ is right, but insulin loss produces hyperglycemia, not fat malabsorption; greasy stools reflect loss of exocrine enzymes rather than an endocrine hormone.
Question 2GastrointestinalMedium
A 48-year-old man with a 25-year history of heavy alcohol use presents with recurrent, dull epigastric pain that radiates to his back and improves when he leans forward. Over the past year he has lost 12 kg and reports pale, bulky, foul-smelling stools that float and are difficult to flush. He was recently diagnosed with diabetes. He continues to drink and smokes one pack of cigarettes daily. Serum lipase is normal. CT of the abdomen shows scattered pancreatic calcifications, a dilated main pancreatic duct, and parenchymal atrophy. Which of the following is the most likely diagnosis?
AAutoimmune IgG4 pancreatitis
BRecurrent acute pancreatitis
CChronic calcific pancreatitis
DPancreatic ductal adenocarcinoma
EMain-duct IPMN of the pancreas
Reveal answer & full explanation
Correct answer: C — Chronic calcific pancreatitis
AAutoimmune IgG4 pancreatitis
BRecurrent acute pancreatitis
CChronic calcific pancreatitis✓
DPancreatic ductal adenocarcinoma
EMain-duct IPMN of the pancreas
Why Chronic calcific pancreatitis is correct
The classic late-stage triad of pancreatic calcifications + steatorrhea + diabetes mellitus is essentially pathognomonic for chronic pancreatitis, and all three are present here.
Long-standing heavy alcohol use plus smoking are the dominant toxic-metabolic risk factors (TIGAR-O 'T'); smoking independently accelerates progression.
Pain that radiates to the back and eases with leaning forward, weight loss, and greasy floating stools reflect exocrine insufficiency from progressive acinar loss.
A normal lipase does NOT exclude the diagnosis: the atrophic, burned-out gland produces little enzyme, so lipase rises only during acute flares.
Why the others are wrong
Pancreatic ductal adenocarcinoma — a key mimic to exclude, but it classically causes a discrete pancreatic-head mass with painless obstructive jaundice and an elevated CA 19-9, not diffuse calcifications with ductal dilation and parenchymal atrophy; calcifications point to a chronic fibroinflammatory process.
Recurrent acute pancreatitis — presents as distinct episodes with a clearly elevated lipase and normalization between attacks, and lacks the established structural changes (calcifications, atrophy) and exocrine/endocrine failure seen here.
Autoimmune IgG4 pancreatitis — a genuine mimic of chronic pancreatitis, but type 1 disease produces a diffusely enlarged sausage-shaped gland with a hypoattenuating capsule-like rim and a diffusely narrowed, featureless main duct, the opposite of the coarse calcifications, dilated main duct, and atrophy seen after 25 years of heavy alcohol use.
Main-duct IPMN of the pancreas — is tempting because it also dilates the main pancreatic duct and can cause weight loss, new-onset diabetes, and exocrine insufficiency, but it typically presents in the 60s or 70s with a mucin-distended duct, often with mucin extruding from a bulging papilla, whereas scattered parenchymal calcifications with gland atrophy after 25 years of heavy drinking and smoking are the signature of chronic calcific pancreatitis.
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Chronic Pancreatitis outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Established CP: characteristic imaging findings (calcifications, ductal dilation, pseudocysts) + symptoms ± exocrine/endocrine insufficiency. Early CP: more challenging; EUS Rosemont criteria, pancreatic function testing, and longitudinal observation.
Labs
Lipase/amylase — often NORMAL in established CP (atrophic gland); elevated only during flares
Pancreatic enzyme replacement therapy (PERT) — pancrelipase taken during meals, starting at ≥40,000 lipase units per meal and half that dose with snacks, titrated to symptoms and weight; uncoated formulation with concurrent PPI for some patients
Treat diabetes — insulin often required (type 3c diabetes — brittle, prone to hypoglycemia due to glucagon deficiency)
Nutritional support: low-fat diet only if severe steatorrhea; supplement fat-soluble vitamins (ADEK), calcium, B12
Endoscopic therapy: ERCP with pancreatic duct stenting, stone extraction, ESWL for large stones — selected patients with ductal disease
Surgical decompression — lateral pancreaticojejunostomy (Puestow) for dilated main duct (>7 mm) and refractory pain; Frey, Beger, or Whipple procedures for head-predominant disease
Celiac plexus block (limited durability)
Total pancreatectomy with islet auto-transplantation — refractory pain with debilitating disease (specialized centers)
Treat IgG4-related autoimmune pancreatitis with corticosteroids — DRAMATIC response (often confused with cancer); maintain with low-dose steroid or rituximab
Type 3c diabetes (pancreatogenic) is brittle and prone to severe hypoglycemia from glucagon deficiency — counsel patients and consider continuous glucose monitoring.
Pancreatic enzyme replacement (PERT) — start at ≥40,000 lipase units per meal (half with snacks); concurrent PPI for non-enteric-coated formulations; titrate to symptom control.
Always exclude pancreatic cancer in patients with new or worsening pain — CT, MRI, EUS-FNA as indicated.
IgG4-related autoimmune pancreatitis (type 1) responds dramatically to corticosteroids — sausage-shaped pancreas, elevated IgG4, other organ involvement (sclerosing cholangitis, retroperitoneal fibrosis, sialadenitis).
PRSS1 mutation (hereditary pancreatitis) — 80% lifetime risk of CP; consider screening for pancreatic cancer.
Smoking accelerates CP progression independently — counseling cessation is critical.
Total pancreatectomy with islet auto-transplantation can be considered in highly selected refractory patients at experienced centers.
Tropical (juvenile) calcific pancreatitis: developing countries; SPINK1 mutations; large ductal stones; presents in adolescence with severe pain and diabetes.
References
ACG 2020 — Gardner TB et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol 2020;115:322-339
AGA 2023 — Whitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology 2023;165:1292-1301
UEG (HaPanEU) 2018 — Dominguez-Munoz JE, Drewes AM, Lindkvist B, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology 2018;18:847-854
Practice Gastrointestinal questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.